Insights on the Intravenous Solutions Global Market to 2027 - Featuring Ajinomoto, Grifols and Omnicare Among Others - ResearchAndMarkets.com

·4 min read

DUBLIN, January 18, 2022--(BUSINESS WIRE)--The "Intravenous (IV) Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$15 Billion by 2026, growing at a CAGR of 6.8% over the analysis period.

Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to grow at a 7.1% CAGR to reach US$11 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period.

This segment currently accounts for a 32.8% share of the global Intravenous (IV) Solutions market. Total parenteral nutrition (TPN) is an approach that involves intravenous infusion of carefully balanced blend of minerals and vitamins. The treatment is administered in life-threatening scenarios such as intestinal failure, where a patient is unable to digest and absorb essential nutrients including minerals and vitamins required for survival.

The U.S. Market is Estimated at $4.1 Billion in 2021, While China is Forecast to Reach $1.4 Billion by 2026

The Intravenous (IV) Solutions market in the U.S. is estimated at US$4.1 Billion in the year 2021. The country currently accounts for a 38.86% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$684.3 Million by the end of the analysis period.

Select Competitors (Total 67 Featured):

  • Ajinomoto

  • Anhui Medipharm Co. Ltd

  • B. Braun Melsungen AG

  • Baxter International

  • Fresenius Kabi AG

  • Grifols

  • ICU Medical Inc.

  • Omnicare

  • Vifor Pharma

  • Wuhan Uni-Pharma Bio-Tech Co. Ltd

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of COVID-19 Pandemic and Looming Global Recession

  • 2020: A Year of Disruption & Transformation

  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?

  • Pandemic Affects Demand for Intravenous Solutions

  • Elective Surgeries Report Roller-Coaster Ride Amid COVID-19, Affecting Demand for IV Solutions

  • COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times

  • An Introduction to Intravenous (IV) Solutions

  • Types of Intravenous Solutions

  • Global Market Prospects & Outlook

  • TPN Emerges as the Largest Segment in the IV Solutions Market

  • Single Dose Amino Acid Solutions: The Major Nutrient Type

  • Developed Economies Lead, Developing Regions to Propel Future Growth

  • Competition

  • World Brands

  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions

  • Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions

  • Rising Cancer Incidence and Need for Nutritional Support

  • Alarming Rise in Diabetes Incidence Worldwide

  • Nutritional Management of Patients with Neurological Diseases

  • Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration

  • Growing Numbers of Pre-term Births Drives Demand for IV Solutions

  • Demand Rises for Home Intravenous Nutritional Therapies

  • Premixed IV Nutrition: A Step towards Safer Medication Practices

  • Premixed Formulations Present Efficient Delivery System

  • Iron Replacement Therapies: Potential for Growth

  • Growing Demand for Low-Cost Intravenous Nutrition Solutions

  • COVID-19 Outbreak: Combating Medication Errors in IV Infusion

  • Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market

  • Increasing Healthcare Expenditure Creates Conducive Environment

  • Challenges Confronting IV Solutions Market

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/lurg1p

View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005629/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting